|
1
|
Buzzetti E, Pinzani M and Tsochatzis EA:
The multiple-hit pathogenesis of non-alcoholic fatty liver disease
(NAFLD). Metabolism. 65:1038–1048. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Younossi Z, Anstee QM, Marietti M, Hardy
T, Henry L, Eslam M, George J and Bugianesi E: Global burden of
NAFLD and NASH: Trends, predictions, risk factors and prevention.
Nat Rev Gastroenterol Hepatol. 15:11–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bril F, Sninsky JJ, Baca AM, Superko HR,
Portillo Sanchez P, Biernacki D, Maximos M, Lomonaco R, Orsak B,
Suman A, et al: Hepatic steatosis and insulin resistance, but not
steatohepatitis, promote atherogenic dyslipidemia in NAFLD. J Clin
Endocrinol Metab. 101:644–652. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tilg H, Moschen AR and Roden M: NAFLD and
diabetes mellitus. Nat Rev Gastroenterol Hepatol. 14:32–42. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olsson K, Saini A, Strömberg A, Alam S,
Lilja M, Rullman E and Gustafsson T: Evidence for vitamin D
receptor expression and direct effects of 1α, 25(OH)2D3 in human
skeletal muscle precursor cells. Endocrinology. 157:98–111. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rossberg W, Saternus R, Wagenpfeil S,
Kleber M, März W, Reichrath S, Vogt T and Reichrath J: Human
pigmentation, cutaneous vitamin D synthesis and evolution: Variants
of genes (SNPs) involved in skin pigmentation are associated with
25(OH)D serum concentration. Anticancer Res. 36:1429–1437.
2016.PubMed/NCBI
|
|
7
|
Pritchett K, Pritchett R, Ogan D, Bishop
P, Broad E and LaCroix M: 25(OH)D status of elite athletes with
spinal cord injury relative to lifestyle factors. Nutrients.
8:1–11. 2016. View Article : Google Scholar
|
|
8
|
Della Corte C, Carpino G, De Vito R, De
Stefanis C, Alisi A, Cianfarani S, Overi D, Mosca A, Stronati L,
Cucchiara S, et al: Docosahexanoic acid plus vitamin D treatment
improves features of NAFLD in children with serum vitamin D
deficiency: Results from a single centre trial. PLoS One.
11:e01682162016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goswami R, Saha S, Sreenivas V, Singh N
and Lakshmy R: Vitamin D-binding protein, vitamin D status and
serum bioavailable 25(OH)D of young Asian Indian males working in
outdoor and indoor environments. J Bone Miner Metab. 35:177–184.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brunt EM, Kleiner DE, Wilson LA, Belt P
and Neuschwande-Tetri BA; NASH Clinical Research Network (CRN), :
Nonalcoholic fatty liver disease (NAFLD) activity score and the
histopathologic diagnosis in NAFLD: Distinct clinicopathologic
meanings. Hepatology. 53:810–820. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Graffy PM and Pickhardt PJ: Quantification
of hepatic and visceral fat by CT and MR imaging: Relevance to the
obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol.
89:201510242016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Targher G and Byrne CD: Obesity:
Metabolically healthy obesity and NAFLD. Nat Rev Gastroenterol
Hepatol. 13:442–444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Forlani G, Giorda C, Manti R, Mazzella N,
De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida
P, et al AMD-Annals Study Group, : The burden of NAFLD and its
characteristics in a nationwide population with type 2 diabetes. J
Diabetes Res. 2016:29319852016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Godoy P, Hewitt NJ, Albrecht U, Andersen
ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger
J, et al: Recent advances in 2D and 3D in vitro systems using
primary hepatocytes, alternative hepatocyte sources and
non-parenchymal liver cells and their use in investigating
mechanisms of hepatotoxicity, cell signaling and ADME. Arch
Toxicol. 87:1315–1530. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim D and Kim WR: Nonobese fatty liver
disease. Clin Gastroenterol Hepatol. 15:474–485. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feldman A, Eder SK, Felder TK, Kedenko L,
Paulweber B, Stadlmayr A, Huber-Schönauer U, Niederseer D, Stickel
F, Auer S, et al: Clinical and metabolic characterization of lean
Caucasian subjects with non-alcoholic fatty liver. Am J
Gastroenterol. 112:102–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lurbe E, Agabiti-Rosei E, Cruickshank JK,
Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G,
Pall D, et al: 2016 European Society of Hypertension guidelines for
the management of high blood pressure in children and adolescents.
J Hypertens. 34:1887–1920. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Houghton D, Thoma C, Hallsworth K, Cassidy
S, Hardy T, Burt AD, Tiniakos D, Hollingsworth KG, Taylor R, Day
CP, et al: Exercise reduces liver lipids and visceral adiposity in
patients with nonalcoholic steatohepatitis in a randomized
controlled trial. Clin Gastroenterol Hepatol. 15:96–102.e3. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Panahi Y, Kianpour P, Mohtashami R, Jafari
R, Simental- Mendía LE and Sahebkar A: Curcumin lowers serum lipids
and uric acid in subjects with nonalcoholic fatty liver disease: A
randomized controlled trial. J Cardiovasc Pharmacol. 68:223–229.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan S, Bal H, Khan ID and Paul D:
Evaluation of the diabetes in pregnancy study group of India
criteria and Carpenter-Coustan criteria in the diagnosis of
gestational diabetes mellitus. Turk J Obstet Gynecol. 15:75–79.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kearns CE, Schmidt LA and Glantz SA: Sugar
industry and coronary heart disease research: A historical analysis
of internal industry documents. JAMA Intern Med. 176:1680–1685.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alwahsh SM and Gebhardt R: Dietary
fructose as a risk factor for non-alcoholic fatty liver disease
(NAFLD). Arch Toxicol. 91:1545–1563. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cashman KD, Dowling KG, Škrabáková Z,
Gonzalez-Gross M, Valtueña J, De Henauw S, Moreno L, Damsgaard CT,
Michaelsen KF, Mølgaard C, et al: Vitamin D deficiency in Europe:
Pandemic? Am J Clin Nutr. 103:1033–1044. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cavalier E, Lukas P, Bekaert AC, Peeters
S, Le Goff C, Yayo E, Delanaye P and Souberbielle JC: Analytical
and clinical evaluation of the new Fujirebio Lumipulse®G
non-competitive assay for 25(OH)-vitamin D and three immunoassays
for 25(OH)D in healthy subjects, osteoporotic patients, third
trimester pregnant women, healthy African subjects, hemodialyzed
and intensive care patients. Clin Chem Lab Med. 54:1347–1355.
2016.PubMed/NCBI
|
|
25
|
Prasad P and Kochhar A: Interplay of
vitamin D and metabolic syndrome: A review. Diabetes Metab Syndr.
10:105–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pacifico L, Andreoli GM, D'Avanzo M, De
Mitri D and Pierimarchi P: Role of osteoprotegerin/receptor
activator of nuclear factor kappa B/receptor activator of nuclear
factor kappa B ligand axis in nonalcoholic fatty liver disease.
World J Gastroenterol. 24:2073–2082. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hanley AJ, Williams K, Festa A,
Wagenknecht LE, D'Agostino RB Jr and Haffner SM: Liver markers and
development of the metabolic syndrome: The insulin resistance
atherosclerosis study. Diabetes. 54:3140–3147. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chung GE, Kim D, Kwak MS, Yang JI, Yim JY,
Lim SH and Itani M: The serum vitamin D level is inversely
correlated with nonalcoholic fatty liver disease. Clin Mol Hepatol.
22:146–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Patel YA, Henao R, Moylan CA, Guy CD,
Piercy DL, Diehl AM and Abdelmalek MF: Vitamin D is not associated
with severity in NAFLD: Results of a paired clinical and gene
expression profile analysis. Am J Gastroenterol. 111:1591–1598.
2016. View Article : Google Scholar : PubMed/NCBI
|
